Cyclo (RGDyC)
Cyclo (RGDyC) is a cyclic pentapeptide with anti-angiogenic abilities. Cyclo (RGDyC) can be combined with liposome delivery systems for research on ocular neovascular diseases and cancer[1][2].
Product Specifications
CAS Number
[1206475-79-7]
UNSPSC
12352209
Target
Biochemical Assay Reagents
Type
Peptides
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cyclo-rgdyc.html
Purity
98.29
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
O=C([C@@H](NC(CNC([C@@H](NC([C@@H](NC1=O)CS)=O)CCCNC(N)=N)=O)=O)CC(O)=O)N[C@@H]1CC2=CC=C(C=C2)O
Molecular Formula
C24H34N8O8S
Molecular Weight
594.64
References & Citations
[1]Lu Y, et al. Aqueous synthesized near-infrared-emitting quantum dots for RGD-based in vivo active tumour targeting. Nanotechnology. 2013 Apr 5;24 (13) :135101.|[2]Tang M, et al. Photostable and Biocompatible Fluorescent Silicon Nanoparticles-Based Theranostic Probes for Simultaneous Imaging and Treatment of Ocular Neovascularization. Anal Chem. 2018 Jul 3;90 (13) :8188-8195.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
